Resveratrol: A unique antioxidant offering a multi-mechanistic approach for treating aging skin

Journal of Drugs in Dermatology

Volumn 12, Issue 12, 2013, Pages 1389-1394

  Farris, Patricia ^a,b   Krutmann, Jean ^g   Li, Yuan Hong ^h   McDaniel, David ^c,d,e,f   Krol, Yevgeniy ⁱ  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Old Metairie Dermatology   (United States)

^c Institute of Anti Aging Research   (United States)

^d EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^e HAMPTON UNIVERSITY   (United States)

^f OLD DOMINION UNIVERSITY   (United States)

^g IUF LEIBNIZ RESEARCH INSTITUTE FOR ENVIRONMENTAL MEDICINE   (Germany)

^h CHINA MEDICAL UNIVERSITY   (China)

ⁱ SkinCeuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; RESVERATROL;

AGING; ANTIOXIDANT ACTIVITY; ARTICLE; CELL ENERGY; CELL PROTECTION; CUTANEOUS PARAMETERS; DIET RESTRICTION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; HUMAN; MITOCHONDRION; OXIDATIVE STRESS;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIOXIDANTS; HUMANS; MITOCHONDRIA; SIGNAL TRANSDUCTION; SKIN AGING; STILBENES;

EID: 84890914167     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Takaoka MJ. Of the phenolic substance of white hellebore (Veratrum grandiflorum Loes, fil.). J Faculty Sci. Hokkaido Imperia University. 1940;3:1-16.
2. Siemann EH, Creasy LL. Concentration of the phytoalexin resveratrol in wine. Am J Eno Vitic. 1992;43(1):49-52.
3. Harikumar KB, Aggarwal BB. Resveratrol. A multitargeted agent for age-associated chronic diseases. Cell Cycle. 2008;7(8):1020-1035.
4. Su HC, Hung LM, Chen JK. Resveratrol, a red wine antioxidant, possessing an insulin-like effect in streptozotiocin-induced diabetic rats. Am J Physiol Endocrinol Metab. 2006:290:1339-1346.
5. Jang M, Cai L, Udeani Go, Slowing KV et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997;275:218-220.
6. Magyar K, Halmosi R, Palfi A, Feher G, et al. Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease. Clin Hemorheol Microcirc. 2012;50(3):179-87.
7. Ungvari et al. Resveratrol increases vascular oxidative stress resistance. Am J Physiol Heart Circ Physiol. 2007;292:H2417-H2424.
8. Arikumar et al. Resveratrol: A multitargeted agent for age-associated chronic disease. Cell Cycle. 2008;7(8):1020-1035.
9. Stojanovic S, Sprinz H, Brede O. Efficiency and mechanism of antioxidant action of trans-resveratrol and its analogues in the radical liposome oxidation. Arch Biochem Biophys. 2001;391(1):79-89.
10. Leonard SS, Xia C, Jiang BH, Stinetefelt, et al. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun. 2003;309(4):1017-26
11. Fang JG, Lu M, Chen Zh et al. Antioxidant effects of resveratrol and its analogues against the free radical induced peroxidation of linoleic acid in micelles. Chemistry. 2002;8(18):4191-4198.
12. Wallace DC. Mitochondrial DNA mutations in disease and aging. Environ Mol Mutagen. 2012;51(5):440-450.
13. Csiszar A et al. Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol. 2009;297(1):H13-H20.
14. Ungvari Z et al. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cell. Am J Physiol Heart Circ Physiol. 2009;297(5):H1876-H1881.
15. Baur JA. Resveratrol, sirtuins, and the promise of a DR mimetic. Mech Ageing Dev. 2010;131(4);261-269.
16. Dali-Youcef N, Lagouge M, Froelich S, et al. The "magnificent seven": function, metabolism and longevity. Ann Med. 2007;39(5):335-345.
17. Gerhart-Hines et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1 alpha. Embo J. 2007;26(7):1913- 1923.
18. Lagouge M, Argmann C, Gerhart-Hines, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell. 2006;127(6):1109-1122.
19. Barger JL, Kayo T, Vann JM, et al. A low dose of dietary resveratrol partially mimics calorie restriction and retards ageing parameters in mice. Plos ONE. 2009;3(6):e2664.
20. Timmers S, Konings E, Bilet L, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese human. Cell Metab. 2011;14(5):612-622.
21. Michan S, Sinclair D: Sirtuins in mammals: Insights into their biological function. Biochem J. 2007;404(1):1-13.
22. Howitz KT, Bitterman KJ, Cohen HY t al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003;425(6954);191- 196.
23. Ungvari Z et al 2010 Resveratrol confers endothelial protection via activation of the antioxidant transcription factor NRF2. Am J Physiol Heart Circ Physiol. 2010;299(1):H18-H24.
24. Nguyen T, Sherratt PJ, Nioi P, Yang CS, Pickett CB. Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1. J Biol Chem. 2005;280(37):32485-32492.
25. Tufekci KU, Bayin EC, Genc S, Genc K. The Nrf2/ARE Pathway: A promising target to counteract mitochondrial dysfunction in Parkinson's Disease. Parkinsons Dis. 2010;2011:314082.
26. Cheng AS, Cheng YH, Chiou CH, Chang TS. Resveratrol Upregulates Nrf2 Expression To Attenuate Methylglyoxal-Induced Insulin Resistance in Hep G2 Cell. J Agric Food Chem. 2012;60(36):9180-9187.
27. Kim HJ, Vaziri ND. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress inflammation in chronic renal failure. Am J Physiol Renal Physiol. 2010;298(3):F662-671.
28. Ungyari Z, Sonntag WE, Cabo R, Bauer JA, Csiszar A. Mitochondrial Protection by Resveratrol. Exerc sport Sci Rev. 2012;39(3):128-132.
29. Kode et al. Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-medicated oxidative stress in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2008; 294(3):L478-L488.
30. Aggarawal BB, Ghardwaj A, Aggarwal RS, et al. Role of resveratrol in prevention and therapy of cancer; preclinical and clinical studies. Anticancer Res. 2004;24(5):2783-2840.
31. Ulrich S, Wolter F, Stein JM. Molecular mechanisms of the chemopreventative effects of resveratrol and its analogs in carcinogenesis. Mol Nutr Food Res. 2005;49(5):452-461.
32. Osmund GW et al. Enhancing melanoma treatment with resveratrol. J Surg Res. 2010;2(1):109-115.
33. Aziz MH, Reagan-Shaw S, Wu J, et al. Chemoprevention of skin cancer by grape constituents resveratrol: Relevance to human disease? FASEB J. 2005;(9)19:1193-1195.
34. Afaq F, Adhami VM, Ahmad N Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice. Toxicol Appl Pharmacol. 2003;186(1):28-37.
35. Krutmann J, Schroeder P: Role of mitochondria in photoaging of human skin: The defective powerhouse moel. J Invest Dermatol Symp Proc. 2009;14:44-49.
36. Sander CS, Chang H, Salzmann S, Muller CS, Ekanayake-Mudiyanselage S, Elsner P, et al. Photaging is asscoaited with protein oxidation in human skin in vivo. J Invest Dermatol. (2002) 118:618-25
37. Fisher GJ, Talwar HS, Lin J, P Lin, McPhillips F, Wang Z, Li X, Wan Y, Kang S, Voorhees JJ. Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo. J Clin Invest. 1998;101(6):1432-1440.
38. Dhar A, Young MR, Colburn NH. The role of AP-1, NF-kappaB and ROS/ NOS in skin carcinogenesis: the JB6 model is predictive. Mol Cell Biochem. 2002;234-235(1-2):185-193.
39. Fisher GJ, Wang ZQ, Datta S, Varani J, Kang S, Voorhees JJ. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med. 1997;337(20):1419-1428.
40. Miyazaki Y, Tsukazaki T, Hirota Y, Yonekura A, Osaki M, Shindo H, Yamashita S. Dexamethasone inhibition of TGF beta-induced cell growth and type II collagen mRNA expression through ERK-integrated AP-1 activity in cultured rat articular chondrocytes. Osteoarthritis Cartilage. 2000;8(5):378-385.
41. Avouac J et al. Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis. Arthritis Rheum. 2012;64(5):1642-1652.
42. Kaufman C and Fuchs E. It's got you covered:Nf-kB in the epidermis. J Cell Biol. 2000;149(5):999- 1004.
43. Tilstra JS et al. NF-kB inhibition delays DNA damage-induced senescence and aging in mice. J Clin Invest. 2012;122(7):2601-2612.
44. Kundu JK, Shin YK, Surh YJ, et al. Reveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NRkappaß and AP-1 as prime targets. Biochem Pharmacol. 2006;72(11):1506-1515.
45. Adhami VM, Afaq F, Ahmad N. Suppression of Ultraviolet B Exposure-Mediated Activation of NF-kB in Normal Human Keratinocytes by Resveratrol. Neoplasia. 2003;5(1):74-82
46. Gehm BD, McAndrews JM, Chien PY, et al. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci. USA 1997;94(25):14138-14143.
47. Castelo-Branco C, Duran M, Gonzalez-Merlo J. Skin collagen changes related to age and hormone replacement therapy. Maturitas. 1992;15(2):113-119.
48. Newton RA, Cook AL, Roberts DW, Leonard JH, Sturm RA. Post-transcriptional regulation of melanin biosynthesis enzymes by cAMP and resveratrol in human melanocytes. J Invest Dermatol. 2007;127(9):2216-2227.
49. Ohguchi K, Tanka T, Ito T, et al. Inhibitory effects of resveratrol derivatives from dipterocarpaceae plants on tyrosinase activity. Biosci Biotechnol Biochem. 200;67(7):1587-1589.
50. Newton et al. Post-transcriptional regulation of melanin biosynthetic enzymes by cAMP and resveratrol in human melanocytes. Invest Dermatol. 2007;127(9):2216-27.
51. Goldberg DM, Yan J, Solease GJ. Absorption of three wine-related polyphenols in three different matrices in healthy subjects. Clin Biochem. 2003;36(1):79-87.
52. Cottart CH, Nivet-Antoine V, Laguillier-Morizot C, Beaudeux JL. Resveratrol bioavailability and toxicity in humans. Mol Nutr Food Res. 2010;54(1):7-16.
53. Bastianetto S, Dumont Y, Duranton A, Vercauteren F, Brenton L, Quirion R. Protective action of resveratrol in human skin: Possible involvement of specific receptor binding sites. PLoS One. 2010;5(9):e12935 (McGill University and L'Oreal Open Research)
54. Rius C et al. Trans- but not cis-resveratrol impairs angiotensin-II- mediated vascular inflammation through inhibition of NF-kB activation and peroxisome proliferator-activated receptor-gamma upregulation. J Immunol. 2010;185(6):3718-3727.
55. Waterhouse AL, Trela BC. Resveratrol: isomeric molar absorptivities and stability. J Agric Food Chem. 1996;44(5):1253-1257.
56. Belguendouz, L, Fremont & A. Linard. Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem. Pharmacol. 1997;53(9):1347-1355.
57. Hung CF, Lin YK, Huang ZR, Fang JY., Delivery of resveratrol, a red wine polyphenol, from solutions and hydrogels via the skin. Biol Pharm Bull. 2008 May;31(5):955-62.